28 August 2023>: Clinical Research
Impaired Renal Vein Flow in Atrial Fibrillation: A Potential Risk for Renal Dysfunction
Bayram Öztürk 1ABEF , Kemal Göçer 2ADE* , Ekrem Aksu 2ACD , Kamil Doğan 3ABEDOI: 10.12659/MSM.941435
Med Sci Monit 2023; 29:e941435
Table 1 Baseline characteristics of groups.
Clinical features | Atrial fibrillation (n=34) | Sinus rhythm (n=34) | p value |
---|---|---|---|
Age, years | 62.1±9.5 | 58.6±7.8 | 0.108 |
Gender, m | 14 (41.2) | 16 (47.1) | 0.625 |
Hypertension (%) | 24 (70.6) | 26 (76.5) | 0.582 |
Diabetes mellitus (%) | 12 (35.3) | 14 (41.2) | 0.618 |
Hyperlipidemia (%) | 16 (47.1) | 24 (70.6) | |
Thyroid disorder (%) | 6 (17.6) | 0 (0.0) | |
Chronic obstructive pulmonary disease (%) | 7 (20.6) | 7 (20.6) | 1.000 |
Chronic kidney disease (%) | 6 (17.6) | 4 (11.8) | 0.493 |
Smoking (%) | 6 (17.6) | 10 (29.4) | 0.253 |
Heart rate, min | 80.8±18.4 | 76.6±13.7 | 0.284 |